Get started
Allergy Therapeutics plcAllergy Therapeutics plcAllergy Therapeutics plc

Allergy Therapeutics plc

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsSeasonals

AGY chart


Full chart

Key stats


Market capitalization
‪405.15 M‬ GBP
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
—
Net income (FY)
‪−40.22 M‬ GBP
Revenue (FY)
‪55.20 M‬ GBP
Shares float
‪321.58 M‬
Beta (1Y)
0.80

Employees


Employees (FY)
612
Change (1Y)
0
Revenue / Employee (1Y)
‪90.19 K‬ GBP
Net income / Employee (1Y)
‪−65.71 K‬ GBP

About Allergy Therapeutics plc


Sector
Health Technology
Industry
Pharmaceuticals: Other
CEO
Manuel Llobet
Website
allergytherapeutics.com
Headquarters
Worthing
Founded
2004
ISIN
GB00B02LCQ05
FIGI
BBG000F797G5
Allergy Therapeutics Plc is a biotechnology company, which engages in the Research and Development of allergy treatments. The company was founded by Keith Iain Carter in 1998 and is headquartered in Worthing, the United Kingdom.

Check out other big names from the same industry as AGY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

AGY news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of AGY is 8.30 GBX — it has decreased by −5.88% in the past 24 hours. Watch Allergy Therapeutics plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange Allergy Therapeutics plc stocks are traded under the ticker AGY.
AGY stock has fallen by −4.76% compared to the previous week, the month change is a −5.88% fall, over the last year Allergy Therapeutics plc has showed a 93.02% increase.
We've gathered analysts' opinions on Allergy Therapeutics plc future price: according to them, AGY price has a max estimate of 13.00 GBX and a min estimate of 13.00 GBX. Watch AGY chart and read a more detailed Allergy Therapeutics plc stock forecast: see what analysts think of Allergy Therapeutics plc and suggest that you do with its stocks.
AGY reached its all-time high on Feb 5, 2007 with the price of 67.20 GBX, and its all-time low was 0.35 GBX and was reached on Jun 22, 2023. View more price dynamics on AGY chart.
See other stocks reaching their highest and lowest prices.
AGY stock is 16.00% volatile and has beta coefficient of 0.80. Track Allergy Therapeutics plc stock price on the chart and check out the list of the most volatile stocks — is Allergy Therapeutics plc there?
Today Allergy Therapeutics plc has the market capitalization of ‪405.15 M‬, it has increased by 1.81% over the last week.
Yes, you can track Allergy Therapeutics plc financials in yearly and quarterly reports right on TradingView.
Allergy Therapeutics plc revenue for the last half-year amounts to ‪34.03 M‬ GBX, despite the estimated figure of ‪34.03 M‬ GBX. In the next half-year revenue is expected to reach ‪23.97 M‬ GBX.
No, AGY doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 6, 2025, the company has 612 employees. See our rating of the largest employees — is Allergy Therapeutics plc on this list?
Like other stocks, AGY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Allergy Therapeutics plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Allergy Therapeutics plc technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Allergy Therapeutics plc stock shows the buy signal. See more of Allergy Therapeutics plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.